
In this limited series, we speak with experts to understand the new frontier of anti-obesity drugs, as well as concerns and questions that still remain.
In this limited series, we speak with experts to understand the new frontier of anti-obesity drugs, as well as concerns and questions that still remain.
In this episode, we spoke with an expert about the potential impacts of new guidelines on adolescents, as well as the risks associated with new anti-obesity drugs.
In this final episode, we spoke with Claudia Fox, MD, MPH, FAAP, an associate professor of pediatrics at the University of Minnesota Medical School in Minneapolis.